Since then, newer GLP-1 medications have significantly improved in terms of usability and effectiveness
Large-scale studies, including the STEP trials for semaglutide and real-world data analyses, have reported gallbladder-related adverse events in approximately 13% of patients, compared with lower rates in control groups
It is unknown whether WEGOVY causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions (5.1), Nonclinical Toxicology (13.1)]
She has written for Jase Medical and The Wellness Company on adult and senior health topics
Prescription records showing at least 90 consecutive days of metformin at 1,500 mg daily Documented A1C reduction of less than 1.0% during metformin trial, or Documented intolerance to metformin (GI side effects preventing adherence) Criterion 3: BMI and cardiovascular risk documentation (required in 18 states)